Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive approach. Supporters often highlight the possibility for significant therapeutic gains, principally in ailments where conventional treatments have proven inadequate. However, crucially important to evaluate the significant financial burden associated with CPI stem